Translational strategies in drug development for knee osteoarthritis.

Kyra J Cowan,Kerstin Kleinschmidt-Dörr,Anne Gigout, Flavie Moreau, Jeff Kraines,Robert Townsend,Hugues Dolgos,Julie DeMartino

Drug Discovery Today（2020）

引用 5|浏览0

暂无评分

摘要

•Osteoarthritis (OA) patients are in need of new, disease-modifying drugs.•Disease-modifying OA drugs could target cartilage repair or degradation pathways.•Development of intra-articular OA drugs is associated with unique challenges.•OA drug candidate dosing strategy is defined regardless of administration route.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要